JWA
WST icon

JFS Wealth Advisors’s West Pharmaceutical WST Stock Holding History

JFS Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
33
+3
+10% +$917 ﹤0.01% 945
2026
Q1 		$7.52K Sell
30
-4
-12% -$995 ﹤0.01% 1055
2025
Q4 		$9.36K Buy
34
+17
+100% +$4.65K ﹤0.01% 1006
2025
Q3 		$4.46K Buy
17
+11
+183% +$2.67K ﹤0.01% 1160
2025
Q2 		$1.31K Sell
6
-5
-45% -$1.07K ﹤0.01% 1502
2025
Q1 		$2.46K Sell
11
-21
-66% -$5.79K ﹤0.01% 1394
2024
Q4 		$10.5K Hold
32
– – ﹤0.01% 836
2024
Q3 		$9.61K Sell
32
-3
-9% -$919 ﹤0.01% 871
2024
Q2 		$11.5K Sell
35
-1
-3% -$353 ﹤0.01% 751
2024
Q1 		$14.2K Buy
36
+9
+33% +$3.33K ﹤0.01% 707
2023
Q4 		$9.51K Sell
27
-3
-10% -$1.06K ﹤0.01% 790
2023
Q3 		$11.3K Hold
30
– – ﹤0.01% 691
2023
Q2 		$11.5K Hold
30
– – ﹤0.01% 691
2023
Q1 		$10.4K Buy
30
+6
+25% +$1.75K ﹤0.01% 707
2022
Q4 		$5.65K Buy
24
+7
+41% +$1.66K ﹤0.01% 946
2022
Q3 		$4K Sell
17
-21
-55% -$6.4K ﹤0.01% 1115
2022
Q2 		$11K Buy
38
+16
+73% +$5.21K ﹤0.01% 749
2022
Q1 		$9K Buy
22
+13
+144% +$5.09K ﹤0.01% 843
2021
Q4 		$4K Buy
+9
New +$3.87K ﹤0.01% 894
2018
Q2 		– Sell
-28
Closed -$2K – 548
2018
Q1 		$2K Hold
28
– – ﹤0.01% 488
2017
Q4 		$3K Buy
+28
New +$2.75K ﹤0.01% 473

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

JFS Wealth Advisors's WST Position: Q2 2026 in Review

JFS Wealth Advisors increased its West Pharmaceutical (WST) stake by 10% in Q2 2026, buying an estimated $917 and bringing the position to 33 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

JFS Wealth Advisors first reported a position in WST in Q4 2017 and has held it in 21 quarters since. The position peaked at $14.2K in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • JFS Wealth Advisors held 33 shares of West Pharmaceutical worth $11.8K as of Q2 2026.
  • JFS Wealth Advisors bought 3 West Pharmaceutical shares in Q2 2026, an estimated $917.
  • West Pharmaceutical made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #945 holding.
  • JFS Wealth Advisors first reported a position in West Pharmaceutical in Q4 2017 and has held it in 21 quarters since.
  • JFS Wealth Advisors's West Pharmaceutical position peaked at $14.2K in Q1 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.